TearScience®, makers of LipiView II with Dynamic Meibomian Imaging™(DMI) and LipiFlow® with Vectored Thermal Pulse™, continues to lead innovation in detecting and treating Meibomian Gland Disease. MGD, a progressive and obstructive disease is distinguished by loss of function and structure in meibomian glands. Affecting about 86% of the 300 million dry eye sufferers worldwide. For information on how TearScience® is improving gland function and alleviating symptoms for patients with MGD, please visit www.TearScience.com.
Brands: Korb Meibomian Gland Evaluator™ (MGE) ,LipiView® II with Dynamic Meibomian Imaging™(DMI™), LipiFlow® with Vectored Thermal Pulse™ (VTP)